#CochraneDaily On #PandaDay (https://t.co/RNocZaqgTH), there's a PANDA trial in the @CochraneLibrary review of the use of degarelix for men with advanced prostate cancer (https://t.co/ARxT9lvFeQ) #prostatecancer #evidencesynthesis @CochraneUrology
Le dégarélix dans le cancer avancé de la prostate récemment diagnostiqué https://t.co/9kBPF1xIQF
RT @CochraneUrology: Hot off the press: Cochrane review on Degarelix for treating advanced hormone‐sensitive prostate cancer: https://t.co/…
RT @CochraneUrology: Hot off the press: Cochrane review on Degarelix for treating advanced hormone‐sensitive prostate cancer: https://t.co/…
RT @CochraneUrology: Hot off the press: Cochrane review on Degarelix for treating advanced hormone‐sensitive prostate cancer: https://t.co/…
Hot off the press: Cochrane review on Degarelix for treating advanced hormone‐sensitive prostate cancer: https://t.co/HofMFBNAzb @NiranjanJS @juan_francomd @Cochrane_US @C_Incontinence @arhshepherd @VikramNarayan @EBMUrology @DraganIlic99
New article: Degarelix for treating advanced hormone-sensitive prostate cancer https://t.co/CkKdhmTsih #prostatecancer #oncology https://t.co/W9sS0OpQ7z